Scott D. Kahn's most recent trade in Exagen Inc was a trade of 9,000 Stock Option(right to buy) done . Disclosure was reported to the exchange on June 10, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Exagen Inc | Scott D. Kahn | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jun 2025 | 9,000 | 9,000 | - | - | Stock Option(right to buy) | |
| Exagen Inc | Scott D. Kahn | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jun 2024 | 15,000 | 15,000 | - | - | Stock Option(right to buy) |